Ir para o conteúdo principal

Repro Med Systems (NASDAQ: KRMD) — Perfil da empresa, notícias e dados financeiros

Logo de Repro Med Systems
KRMD Repro Med Systems
Repro Med Systems primary media
Perfil da empresa

Repro Med Systems

Repro Med Systems, also known colloquially as KORU Medical Systems (NASDAQ:KRMD), specializes in the design, manufacture, and marketing of innovative medical devices for the home healthcare market. The company is dedicated to improving the lives of patients by offering products that focus on subcutaneous drug delivery for chronic conditions, enabling users to manage their treatments more comfortably and effectively outside of a clinical setting. KORU Medical Systems is committed to advancing healthcare by expanding its product line, leveraging cutting-edge technology to meet the evolving needs of patients, and ensuring high-quality and accessible medical solutions. Its main objectives include enhancing patient care, driving innovation in home healthcare solutions, and expanding its market presence globally through strategic partnerships and product development.

Resumo

Public USParticipação acionária
1980Ano de fundação
82Funcionários
New Jersey, United StatesSede
Carregando mapa...
Presença global

Operações

Todos os locais
United States

Produtos e/ou serviços de Repro Med Systems

  • FREEDOM60 and FREEDOMEdge Syringe Infusion Systems, designed for safe, portable medication delivery.
  • Precision Flow Rate Tubing and HIgH-Flo Subcutaneous Safety Needle Sets, enhancing infusion accuracy and patient comfort.
  • Freedom Flow Rate Calculator, a tool aiding clinicians in prescribing accurate infusion rates.
  • RES-Q-VAC, a portable, manual suction system used for airway clearance.
  • Easy-Load Syringe Pump Sets, tailored for simplicity and efficiency in various infusion therapies.
  • Training and educational programs for healthcare providers and patients, ensuring effective use of their infusion products.

equipe executiva do Repro Med Systems

  • Adam KalbermattenPresident & CEO
  • Thomas AdamsCFO, Secretary & Treasurer
  • Christopher PazdanChief Operating Officer
  • Eric SchillerChief Technology Officer

Principais indicadores financeiros

Resultados divulgados pela Repro Med Systems, em USD.

Cap. de mercado
145,6 mi
Receita (TTM)
45,1 mi
P/L
—
LPA (diluído, TTM)
-0.0
Dividend yield
—
Margem de lucro
-4.0%
Receita e lucro anuais da Repro Med Systems
Fim do ano fiscalReceitaResultado operacionalLucro líquido
41,1 mi-3 mi-2,6 mi
33,6 mi-6,4 mi-6,1 mi
28,5 mi-10,3 mi-13,7 mi
27,9 mi-10,8 mi-8,7 mi